A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Research Bookmark and Share

Research at City of Hope

Since its founding in 1913, City of Hope has achieved numerous scientific breakthroughs and pioneered many lifesaving procedures that have benefited patients worldwide. Today, we are recognized as a leading research and treatment center dedicated to the prevention, treatment and cure of cancer and other life-threatening diseases. Our mission is to shorten the time from initial research idea to new treatment in order to quickly bring cures to patients. For more information about current lung cancer clinical trials at City of Hope, visit our Clinical Trials page. 

Some of our recent Lung Cancer Research Program studies: 
  
 
  • We are striving to understand how lung cancer spreads so that we can work to prevent metastasis. Some patients will develop lung cancer spread due to microscopic disease at the time of surgery. We are studying markers of metastatic potential within lymph nodes of patients with completely resected non-small cell lung cancer (NSCLC). We now better understand how the area outside the tumor and the immune system can contribute to cancer spread and are working to find targeted molecules to block tumor metastasis, with the goal of improving survival.
  • Treatment options for advanced stage NSCLC have increased in the last several years and biologic targets have been identified. We continue to evaluate novel therapies through multiple trials of new chemotherapeutic and targeted-therapy agents and novel combinations. As we gain knowledge into the biology of lung cancer, we have also incorporated the evaluation of biomarkers into our trials to better tailor therapies to our patients.
  • Studies with targeted therapies have demonstrated promising results. We seek to improve tumor shrinkage to targeted epidermal growth factor receptor (EGFR) therapy in advanced NSCLC. To this end, we investigated a cyclooxygenase-2 (COX-2) inhibitor, celecoxib, in combination with erlotinib, an EGFR inhibitor. The COX-2 pathway plays a key role in tumor growth, angiogenesis and resistance to therapy. We have completed a randomized trial evaluating the combination, and continue to investigate biomarkers to better understand how to select patients who will receive the greatest benefit from this therapy.
  • We are interested in the investigation of novel agents that target immune modulation through natural products. Patients with advanced lung cancer frequently have abnormalities in the immune system, especially depletion of certain T cells and B cells, which are important to the body's defense. Clinical research has shown that beta-glucans found in certain medicinal mushrooms can exert immune- enhancing activity. We have evaluated MM-IO-001, a solution produced from shiitake mushrooms containing beta-glucans, in patients with advanced non-small cell lung cancer. The study will determine whether the treatment can improve patients' immune system. Future work will evaluate components of the immune system that may inhibit lung cancer growth.
  • The Quality of Life component of our Lung Cancer and Thoracic Oncology Program conducts research to improve quality of life for lung cancer patients and to design effective interdisciplinary interventions to support lung cancer patients and their families. Because lung cancer patients often present with advanced disease, approaches to care are focused on maximizing quality of life through supportive and palliative care.

Research

Research at City of Hope

Since its founding in 1913, City of Hope has achieved numerous scientific breakthroughs and pioneered many lifesaving procedures that have benefited patients worldwide. Today, we are recognized as a leading research and treatment center dedicated to the prevention, treatment and cure of cancer and other life-threatening diseases. Our mission is to shorten the time from initial research idea to new treatment in order to quickly bring cures to patients. For more information about current lung cancer clinical trials at City of Hope, visit our Clinical Trials page. 

Some of our recent Lung Cancer Research Program studies: 
  
 
  • We are striving to understand how lung cancer spreads so that we can work to prevent metastasis. Some patients will develop lung cancer spread due to microscopic disease at the time of surgery. We are studying markers of metastatic potential within lymph nodes of patients with completely resected non-small cell lung cancer (NSCLC). We now better understand how the area outside the tumor and the immune system can contribute to cancer spread and are working to find targeted molecules to block tumor metastasis, with the goal of improving survival.
  • Treatment options for advanced stage NSCLC have increased in the last several years and biologic targets have been identified. We continue to evaluate novel therapies through multiple trials of new chemotherapeutic and targeted-therapy agents and novel combinations. As we gain knowledge into the biology of lung cancer, we have also incorporated the evaluation of biomarkers into our trials to better tailor therapies to our patients.
  • Studies with targeted therapies have demonstrated promising results. We seek to improve tumor shrinkage to targeted epidermal growth factor receptor (EGFR) therapy in advanced NSCLC. To this end, we investigated a cyclooxygenase-2 (COX-2) inhibitor, celecoxib, in combination with erlotinib, an EGFR inhibitor. The COX-2 pathway plays a key role in tumor growth, angiogenesis and resistance to therapy. We have completed a randomized trial evaluating the combination, and continue to investigate biomarkers to better understand how to select patients who will receive the greatest benefit from this therapy.
  • We are interested in the investigation of novel agents that target immune modulation through natural products. Patients with advanced lung cancer frequently have abnormalities in the immune system, especially depletion of certain T cells and B cells, which are important to the body's defense. Clinical research has shown that beta-glucans found in certain medicinal mushrooms can exert immune- enhancing activity. We have evaluated MM-IO-001, a solution produced from shiitake mushrooms containing beta-glucans, in patients with advanced non-small cell lung cancer. The study will determine whether the treatment can improve patients' immune system. Future work will evaluate components of the immune system that may inhibit lung cancer growth.
  • The Quality of Life component of our Lung Cancer and Thoracic Oncology Program conducts research to improve quality of life for lung cancer patients and to design effective interdisciplinary interventions to support lung cancer patients and their families. Because lung cancer patients often present with advanced disease, approaches to care are focused on maximizing quality of life through supportive and palliative care.
About the Lung Cancer Program


Karen Reckamp, M.D., M.S., co-director of the Lung Cancer and Thoracic Oncology Program, discusses lung cancer treatment and research at City of Hope.
Lung Cancer Education Group
Susan's Story, Lung Cancer Survivor

Already a breast cancer survivor, Susan was shocked to learn she'd been diagnosed with lung cancer, though she had never smoked. But she didn't give up hope.

Watch the video >>
Medical Minute
 
 
 
The Sheri & Les Biller Patient and Family Resource Center embodies the heart and soul of City of Hope’s mission to care for the whole person.
NEWS & UPDATES
  • Jonathan Yamzon, M.D., assistant professor of surgery in the Division of Urology and Urologic Oncology, explains his approach to what’s known as “active surveillance” of men with prostate cancer.  Patients need to be educated about their treatment options, he writes. Active surveillance eligib...
  • For most prostate cancer patients, surgery or radiation therapy is the initial and primary treatment against the disease. But some patients can benefit from chemotherapy and hormone therapy too, especially if there are signs of a relapse or if the cancer has spread beyond the prostate gland. Here, Cy Stein, M.D...
  • Cancer research has yielded scientific breakthroughs that offer patients more options, more hope for survival and a higher quality of life than ever before. The 14.5 million cancer patients living in the United States are living proof that cancer research saves lives. Now, in addition to the clinic, hospital an...
  • Advances in cancer treatment, built on discoveries made in the laboratory then brought to the bedside, have phenomenally changed the reality of living with a cancer diagnosis. More than any other time in history, people diagnosed with cancer are more likely to survive and to enjoy a high quality of life. Howeve...
  • While health care reform has led to an increase in the number of people signing up for health insurance, many people remain uninsured or are not taking full advantage of the health benefits they now have. Still others are finding that, although their premiums are affordable, they aren’t able to see the do...
  • Kidney cancer rates and thyroid cancer rates in adults have continued to rise year after year. Now a new study has found that incidence rates for these cancers are also increasing in children — particularly in African-American children. The study, published online this month in Pediatrics, examined childhood ca...
  • Thyroid cancer has become one of the fastest-growing cancers in the United States for both men and women. The chance of being diagnosed with the cancer has nearly doubled since 1990. This year an estimated 63,000 people will be diagnosed with thyroid cancer in the United States and nearly 1,900 people will die ...
  • Older teenagers and young adults traditionally face worse outcomes than younger children when diagnosed with brain cancer and other central nervous system tumors. A first-of-its-kind study shows why. A team of researchers from the departments of Population Sciences and Pathology at City of Hope recently examine...
  • Cancer treatment can take a toll on the mouth, even if a patient’s cancer has nothing to do with the head or throat, leading to a dry mouth, or a very sore mouth, and making it difficult to swallow or eat. Here’s some advice from the National Cancer Institute (NCI)  on how to ease cancer-related dis...
  • Radiation oncology is one of the three main specialties involved in the successful treatment of cancer, along with surgical oncology and medical oncology. Experts in this field, known as radiation oncologists, advise patients as to whether radiation therapy will be useful for their cancer – and how it can best ...
  • There’s more to cancer care than simply helping patients survive. There’s more to cancer treatment than simple survival. Constant pain should not be part of conquering cancer,  insists Betty Ferrell, Ph.D., R.N., director of nursing research and education at City of Hope. She wants patients and caregivers...
  • Even its name is daunting. Systemic mastocytosis is a fatal disease of the blood with no known cure. But a new study suggests a bone marrow transplant may be the answer for some patients. While rare, systemic mastocytosis is resistant to treatment with drugs and, when aggressive, can be fatal within four years ...
  • Could what you eat affect the health of your chromosomes? The short answer is, “Yes.” Researchers led by Dustin Schones, Ph.D., assistant professor in the Department of Cancer Biology, and Rama Natarajan, Ph.D., director of the Division of Molecular Diabetes Research and the National Business Products Industry ...
  • September is Prostate Cancer Awareness Month. Here, Bertram Yuh, M.D., assistant clinical professor in the Division of Urology and Urologic Oncology at City of Hope, explains the importance of understanding the risk factors for the disease and ways to reduce those risks, as well as overall prostate health. “Wha...
  • ** Learn more about prostate health, plus prostate cancer research and treatment, at City of Hope. ** Learn more about getting a second opinion at City of Hope by visiting us online or by calling 800-826-HOPE (4673). City of Hope staff will explain what’s required for a consult at City of Hope and help yo...